Revenue and gross profit: Not reported for QQ2 2026 (null). EBITDA: -$10,105; Operating income: -$10,105; Net income: -$10,105; EPS: -0.40.
YoY and QoQ comparisons (where data exists):
- Operating income YoY: -11.9%; QoQ: -37.3%
- Net income YoY: -11.9%; QoQ: -37.3%
- EPS YoY: -99,900.0%; QoQ: -33.33%
Cash flow and liquidity:
- Net cash provided by operating activities: -$13,000
- Change in working capital: -$2,895; Other working capital: -$2,895
- Net cash used/provided by financing activities: +$13,000
- Free cash flow: -$13,000
Balance sheet highlights:
- Total liabilities: $155,120; Total stockholders’ equity: -$155,120
- Accumulated deficit: -$19,782,171
- Other non-current liabilities: $155,120; Total non-current liabilities: $155,120
- Preferred stock: $8,000; Common stock: $100,103
- Other stockholders’ equity: $19,518,948; Retained earnings: -$19,782,171
- Weighted average shares outstanding: 25,231; EPS diluted: -0.40
Notes: The company reports no revenue or gross margin data and presents a balance-sheet that is heavily influenced by a large accumulated deficit, resulting in negative equity. The data set lacks disclosed cash balance, more granular asset/liability detail, and any stated revenue stream for QQ2 2026.